BioPortfolio - Calyx Therapeutics
Calyx Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/2298-Calyx_Therapeu...
|
BioMed Central | PDF | CLX-0901 (Calyx Therapeutics)
CLX-0901 (Calyx Therapeutics) D Barlocco ... Opinion in Investigational Drugs covers the most important developments in all therapeutic areas, including: ...
http://www.biomedcentral.com/content/pdf/cd-409412.pdf...
|
BioPortfolio - BioPortfolio - Calyx Therapeutics
BioPortfolio - Calyx Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/2298/www.ca...
|
CLX-0901 (Calyx Therapeutics). [Curr Opin Investig Drugs. 2001 ...
Calyx Therapeutics is developing the insulin sensitizer, CLX-0901, as an antidiabetic agent. CLX-0901 is the synthetic analog of CLX-0900 which was ...
http://www.ncbi.nlm.nih.gov/pubmed/11569941...
|
Diabetes 2002 - SMi Conference Varsha Khodiyar
Therapeutics Inc, USA) presented information about the. plant-derived compounds being investigated for antidiabetic. purposes by Calyx Therapeutics. ...
http://www.biomedcentral.com/content/pdf/cd-472764.pdf...
|
BioPortfolio - Biocorporate Search Inflammation1
Calyx Therapeutics uses novel methods to isolate the biologically active molecule from natural plant and animal extracts with demonstrated clinical
activity ...
http://www.bioportfolio.com/biocorporate/Inflammation-compan...
|
American Diabetes Association - 61st Scientific Sessions Clare ...
(CLX, Calyx Therapeutics Inc) demonstrates elevated. glucose uptake in adipocytes, is non-adipogenic, lowers. blood glucose in animals (when
administered ...
http://www.biomedcentral.com/content/pdf/cd-422576.pdf...
|
People - Nature Biotechnology
Calyx Therapeutics (Hayward, CA) has named Mark W. Schwartz president and CEO. He will also join the board of directors. Dr. Schwartz joins the company from
...
http://www.nature.com/nbt/journal/v19/n7/full/nbt0701_687.ht...
|
Synthesis and structure-activity relationship studies of cinnamic ...
Department of Chemistry, Calyx Therapeutics Inc., 3513 Breakwater Avenue, Hayward, CA 94545, USA. p.neogi@att.net. A number of 2,4-thiazolidinedione ...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
Declaration of competing financial interests | Design of effective ...
... Inc., Canji, Inc., Almirall Prodesfarma, Ferring AS, Calyx Therapeutics, ... Trillium Therapeutics, Inc., Hydra Biosciences and Schering Plough. ...
http://www.nature.com/nature/journal/v435/n7042/box/nature03...
|
